News

Article

ABEC Launches 6000-L Single-Use Bioreactor

The company’s Custom Single Run product line now has available bioreactors with working volumes of up to 6000 L.

ABEC, a provider of integrated solutions and services for biopharmaceutical manufacturing, announced on Sept. 10, 2019 that it now provides Custom Single Run (CSR) bioreactors with working volumes up to 6000 L.

The new 6000-L CSR bioreactor increases cell culture capacity per unit of floorspace, which is expected to save on capital spending as well as facility and disposables cost. CSR bioreactors deliver equivalent power per volume compared to stainless-steel bioreactors and can still maintain low-shear mixing, according to the company. The material, instrument, and component supply chains for the new 6000-L vessel remain fully transparent and non-proprietary, giving biopharmaceutical manufacturers better control and flexibility for managing quality, cost, and regulatory compliance.

“We understand that our customers cannot compromise on scalability and cost of goods when realizing other single-use benefits such as multi-product flexibility,” said Scott Pickering, ABEC president and CEO, in a company press release. “In applications where single-use is preferred, with [6000-L] CSR bioreactors, customers can now achieve even greater economies of scale for cell culture production.”

Source: ABEC

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content